Noidecs Launches New THCV Product for UK Market
Noidecs has introduced a THCV-dominant cannabis product to the UK medical market, targeting patients seeking the appetite-suppressing and focus-enhancing properties associated with this rare cannabinoid.
Noidecs, an Australian medical cannabis company with a growing UK market presence, has introduced a THCV-dominant product to the British market — one of the first cannabis medicines in the UK to highlight this rare cannabinoid as its primary therapeutic compound. The launch reflects growing scientific and patient interest in the pharmacology of minor cannabinoids beyond CBD and THC.
What Is THCV?
Tetrahydrocannabivarin (THCV) is a naturally occurring cannabinoid structurally related to THC but with distinct pharmacological properties. Unlike THC, which acts as a cannabinoid receptor agonist and stimulates appetite, THCV acts as a partial antagonist at lower doses — a property that has generated interest in its potential to suppress appetite and improve metabolic parameters.
THCV has also attracted attention for its potential neuroprotective properties and its apparent ability to counteract some of THC's psychoactive effects when present in sufficient concentration. In high doses, THCV does have mild psychoactive properties of its own, distinct from those of THC.
Potential Therapeutic Applications
- Appetite regulation and weight management in patients on long-term THC-dominant regimens
- Potential metabolic benefits for patients with insulin resistance
- Neuroprotective applications in early research for Parkinson's disease and similar conditions
- Counteracting THC-associated appetite stimulation and cognitive side effects
- Energy and focus enhancement noted in patient-reported outcomes
How to Access the Noidecs THCV Product
The product is available through the standard specialist prescription route and will be stocked through selected pharmacy dispensing partners from launch. Patients interested in exploring THCV-containing products should raise the topic with their prescribing physician, who can assess whether it is appropriate given the patient's overall treatment profile.
To explore the full range of products currently available in the UK medical cannabis market, visit our products section or use the comparison tool to assess pricing and availability. Patients interested in the science of individual cannabinoids can explore detailed strain and product profiles in our strain database.
